We focus on pharmaceutical and analytical development of formulations and manufacturing processes using our modern laboratory facilities closely located to the Basle Institute of Technology.
ADD Technologies transfers this know-how to the facilities of allied production partners or to preferred production partners of the customers.
The management of the company has a background of at least 10 years experience in international pharmaceutical development obtained at highly-reputed companies of the pharmaceutical industry in Basle. Together with experienced board members and our scientific advisory board, ADD Technologies is able to offer pharmaceutical development of outstanding quality.
ADD Technologies offers clients highly professional, flexible and cost-effective performance in the technical development of innovative and conventional sterile and solid dosage formulations for New Chemical Entities as well as generic compounds from the prototype development phase to production of clinical material and commercial production. ADD Technologies also supplies the necessary technical documentation for our customer's registration package and ensures compliance with regulatory requirements during clinical production, scale-up, and introductory production campaigns.
| Contact Details: |
| Kägenstrasse 17, |
| Reinach |
| |
| CH-4153 |
| Switzerland |
| Tel: | 41 61 715 97 00 |
| Fax: | +41 61 715 97 01 |
| Email: | |
| WWW: | www.addtechnologies.com/

|
| |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 384 times since April 2007, the link to the organisation's website has been followed 63 times
Search for more companies in Reinach
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
ADD Advanced DrugDelivery Technologies AG